These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19814725)

  • 1. Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome.
    Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
    Br J Pharmacol; 2009 Nov; 158(6):1503-12. PubMed ID: 19814725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
    Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):305-312.e2. PubMed ID: 20189193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
    Chung AW; Au Yeung K; Cortes SF; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Br J Pharmacol; 2007 Apr; 150(8):1075-83. PubMed ID: 17339838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
    Chung AW; Au Yeung K; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Circ Res; 2007 Aug; 101(5):512-22. PubMed ID: 17641224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.
    Chung AW; Yang HH; Radomski MW; van Breemen C
    Circ Res; 2008 Apr; 102(8):e73-85. PubMed ID: 18388324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
    Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
    Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
    J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Naringenin inhibits thoracic aortic aneurysm formation in mice with Marfan syndrome].
    Li ZQ; Yu B; Cai ZY; Wang YB; Zhang X; Zhou B; Fang XH; Yu F; Fu Y; Sun JP; Li W; Kong W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):896-906. PubMed ID: 36241232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalanced synthesis of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome.
    Chung AW; Yang HH; van Breemen C
    Br J Pharmacol; 2007 Oct; 152(3):305-12. PubMed ID: 17641673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiprolol but not losartan improves the biomechanical integrity of the aorta in a mouse model of vascular Ehlers-Danlos syndrome.
    Dubacher N; Münger J; Gorosabel MC; Crabb J; Ksiazek AA; Caspar SM; Bakker ENTP; van Bavel E; Ziegler U; Carrel T; Steinmann B; Zeisberger S; Meienberg J; Matyas G
    Cardiovasc Res; 2020 Feb; 116(2):457-465. PubMed ID: 31056650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens Accentuate TGF-β Dependent Erk/Smad Activation During Thoracic Aortic Aneurysm Formation in Marfan Syndrome Male Mice.
    Tashima Y; He H; Cui JZ; Pedroza AJ; Nakamura K; Yokoyama N; Iosef C; Burdon G; Koyano T; Yamaguchi A; Fischbein MP
    J Am Heart Assoc; 2020 Oct; 9(20):e015773. PubMed ID: 33059492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic remodeling after transverse aortic constriction in mice is attenuated with AT1 receptor blockade.
    Kuang SQ; Geng L; Prakash SK; Cao JM; Guo S; Villamizar C; Kwartler CS; Peters AM; Brasier AR; Milewicz DM
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2172-9. PubMed ID: 23868934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade.
    Moltzer E; te Riet L; Swagemakers SM; van Heijningen PM; Vermeij M; van Veghel R; Bouhuizen AM; van Esch JH; Lankhorst S; Ramnath NW; de Waard MC; Duncker DJ; van der Spek PJ; Rouwet EV; Danser AH; Essers J
    PLoS One; 2011; 6(8):e23411. PubMed ID: 21858106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Clinical Trials of Losartan With and Without β-Blockers to Block Aneurysm Growth in Patients With Marfan Syndrome: A Review.
    Hofmann Bowman MA; Eagle KA; Milewicz DM
    JAMA Cardiol; 2019 Jul; 4(7):702-707. PubMed ID: 31066871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of β-arrestin2-dependent signaling in thoracic aortic aneurysm formation in a murine model of Marfan syndrome.
    Wisler JW; Harris EM; Raisch M; Mao L; Kim J; Rockman HA; Lefkowitz RJ
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1516-27. PubMed ID: 26371162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome.
    Xiong W; Meisinger T; Knispel R; Worth JM; Baxter BT
    Circ Res; 2012 Jun; 110(12):e92-e101. PubMed ID: 22550139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pravastatin reduces Marfan aortic dilation.
    McLoughlin D; McGuinness J; Byrne J; Terzo E; Huuskonen V; McAllister H; Black A; Kearney S; Kay E; Hill AD; Dietz HC; Redmond JM
    Circulation; 2011 Sep; 124(11 Suppl):S168-73. PubMed ID: 21911808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins Reduce Thoracic Aortic Aneurysm Growth in Marfan Syndrome Mice via Inhibition of the Ras-Induced ERK (Extracellular Signal-Regulated Kinase) Signaling Pathway.
    Sato T; Arakawa M; Tashima Y; Tsuboi E; Burdon G; Trojan J; Koyano T; Youn YN; Penov K; Pedroza AJ; Shabazzi M; Palmon I; Nguyen MN; Connolly AJ; Yamaguchi A; Fischbein MP
    J Am Heart Assoc; 2018 Nov; 7(21):e008543. PubMed ID: 30571378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox Dysregulation of Vascular Smooth Muscle Sirtuin-1 in Thoracic Aortic Aneurysm in Marfan Syndrome.
    Budbazar E; Sulser Ponce De Leon S; Tsukahara Y; Liu H; Huangfu Y; Wang Y; Seabra PM; Yang X; Goodman JB; Wan X; Chitalia V; Han J; Seta F
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):e339-e357. PubMed ID: 37288573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.